Influence of genetic and environmental factors on the immunogenicity of Hib vaccine in Gambian twins.

Influence of genetic and environmental factors on the immunogenicity of Hib vaccine in Gambian twins.

Näytä muut versiot (1)

The differences in incidence rates of Haemophilus influenzae type b disease and the variation in Hib conjugate vaccine efficacy achieved among different ethnic groups suggest genetic influences on the immune response to Hib vaccine. The serum anti-PRP antibody concentration of 43 monozygotic (MZ) an...

Bibliografiset tiedot
Päätekijät:	Lee, Y, Newport, M, Goetghebuer, T, Siegrist, C, Weiss, H, Pollard, A, Marchant, A
Aineistotyyppi:	Journal article
Kieli:	English
Julkaistu:	2006

Samankaltaisia teoksia

Influence of genetic and environmental factors on the immunogenicity of Hib vaccine in Gambian twins
Tekijä: Lee, Y, et al.
Julkaistu: (2006)

Safety and immunogenicity of the DTP/HB /Hib combination vaccine: phase I study
Tekijä: Kusnandi Rusmil, et al.
Julkaistu: (2013-12-01)

Natural variation in immune responses to neonatal Mycobacterium bovis Bacillus Calmette-Guerin (BCG) Vaccination in a Cohort of Gambian infants.
Tekijä: Chris Finan, et al.
Julkaistu: (2008-01-01)

Immunogenicity and safety of DTaP/Hib combined vaccination at different inoculation sites among infants
Tekijä: Zhen-jiang LIU, et al.
Julkaistu: (2022-02-01)

Safety and immunogenicity of a combined DTacP-sIPV-Hib vaccine in animal models
Tekijä: Yuntao Zhang, et al.
Julkaistu: (2022-12-01)

Immunogenicity and safety of 3-dose primary vaccination with combined DTPa-HBV-IPV/Hib in Indian infants
Tekijä: Sanjay K. Lalwani, et al.
Julkaistu: (2017-01-01)

Immunogenicity and Reactogenicity of DTPa-IPV/Hib Vaccine Co-administered With Hepatitis B Vaccine for Primary and Booster Vaccination of Taiwanese Infants
Tekijä: Pei-Lan Shao, et al.
Julkaistu: (2011-06-01)

Hib Vaccines: Past, Present, and Future Perspectives
Tekijä: Adi Essam Zarei, et al.
Julkaistu: (2016-01-01)

Safety and immunogenicity of the malaria candidate vaccines FP9 CS and MVA CS in adult Gambian men.
Tekijä: Imoukhuede, E, et al.
Julkaistu: (2006)

Genetic variants of MARCO are associated with susceptibility to pulmonary tuberculosis in a Gambian population.
Tekijä: Bowdish, D, et al.
Julkaistu: (2013)

Immunogenicity of the Tuberculosis Vaccine MVA85A Is Reduced by Coadministration with EPI Vaccines in a Randomized Controlled Trial in Gambian Infants
Tekijä: Ota, M, et al.
Julkaistu: (2011)

Immunogenicity of the tuberculosis vaccine MVA85A is reduced by coadministration with EPI vaccines in a randomized controlled trial in Gambian infants.
Tekijä: Ota, M, et al.
Julkaistu: (2011)

Safety and immunogenicity of malaria vectored vaccines given with routine EPI vaccines in Gambian infants and neonates: a randomized controlled trial
Tekijä: Mensah, V, et al.
Julkaistu: (2017)

Global Hib vaccination: reasons to cheer and fear
Tekijä: Stephen R C Howie
Julkaistu: (2016-03-01)

A phase 4, open-label study to evaluate the safety and immunogenicity of DTaP5-HBV-IPV-Hib in children previously vaccinated with DTaP2-HBV-IPV-Hib or DTaP5-HBV-IPV-Hib (V419-016)
Tekijä: Andrea Guerra, et al.
Julkaistu: (2024-12-01)

Safety and Immunogenicity of Fully Liquid Hexavalent DTaP-IPV-HepB-Hib Vaccine in Healthy Infants in Russian Federation
Tekijä: L. S. Namazova-Baranova, et al.
Julkaistu: (2019-06-01)

Safety and immunogenicity of a fully-liquid DTaP-IPV-Hib-HepB vaccine (Vaxelis™) in premature infants
Tekijä: Marissa B. Wilck, et al.
Julkaistu: (2021-01-01)

Clinical study of safety and immunogenicity of pentavalent DTP-HB-Hib vaccine administered by disposable-syringe jet injector in India
Tekijä: Ashish Bavdekar, et al.
Julkaistu: (2019-06-01)

Occurrence of Haemophilus influenzae type b (Hib) meningitis in a 2 month-old infant in the Hib vaccination era
Tekijä: Yoshiaki Cho, et al.
Julkaistu: (2022-06-01)

The immunogenicity and safety of a reduced PRP-content DTPw-HBV/Hib vaccine when administered according to the accelerated EPI schedule
Tekijä: Collard Alix, et al.
Julkaistu: (2010-10-01)

Lagging Immune Response to <i>Haemophilus influenzae</i> Serotype b (Hib) Conjugate Vaccine after the Primary Vaccination with Hib of Infants in The Netherlands
Tekijä: Leo Schouls, et al.
Julkaistu: (2020-06-01)

Safety and Immunogenicity of Malaria Vectored Vaccines Given with Routine Expanded Program on Immunization Vaccines in Gambian Infants and Neonates: A Randomized Controlled Trial
Tekijä: Victorine A. Mensah, et al.
Julkaistu: (2017-11-01)

A phase III randomized-controlled study of safety and immunogenicity of DTwP-HepB-IPV-Hib vaccine (HEXASIIL®) in infants
Tekijä: Hitt Sharma, et al.
Julkaistu: (2024-02-01)

Phase 1 evaluation of 3 highly immunogenic prime-boost regimens, including a 12-month reboosting vaccination, for malaria vaccination in Gambian men.
Tekijä: Moorthy, V, et al.
Julkaistu: (2004)

Pattern of functional antibody activity against Haemophilus influenzae type b (Hib) in infants immunized with diphtheria-tetanus-pertussis/Hib Brazilian combination vaccine
Tekijä: D.C.S. Matos, et al.
Julkaistu: (2009-12-01)

VACCINATION AGAINST FLU, PNEUMOCOCCAL, MENINGOCOCCAL AND HIB INFECTION OF THE SICKLY CHILDREN
Tekijä: L.S. Namazova, et al.
Julkaistu: (2007-02-01)

VACCINATION AGAINST FLU, PNEUMOCOCCAL, MENINGOCOCCAL AND HIB INFECTION OF THE SICKLY CHILDREN
Tekijä: L.S. Namazova, et al.
Julkaistu: (2007-02-01)

Understanding the impact of Hib conjugate vaccine on transmission, immunity and disease in the United Kingdom.
Tekijä: McVernon, J, et al.
Julkaistu: (2008)

Booster Vaccination against Yellow Fever in Gambian children-(BoVY) -a Phase 3 clinical trial to establish safety and immunogenicity of repeated YF vaccination in healthy Gambian children of different ages [version 1; peer review: 2 approved]
Tekijä: David Jeffries, et al.
Julkaistu: (2024-12-01)

Real-time stability of the Ecuadorian pentavalent DTP-HB-Hib vaccine
Tekijä: Néstor Expósito, et al.

Birth season and environmental influences on blood leucocyte and lymphocyte subpopulations in rural Gambian infants
Tekijä: Moore Sophie E, et al.
Julkaistu: (2008-05-01)

The immunogenicity and safety of a Hib-MenAC vaccine: a non-inferiority randomized, observer-blind trial in infants aged 3-5 months
Tekijä: Yu-Xiao Wang, et al.
Julkaistu: (2017-05-01)

Safety and immunogenicity of a new formulation of a pentavalent DTwP-HepB-Hib vaccine in healthy Indian infants-A randomized study.
Tekijä: Naveena Aloysia D'Cor, et al.
Julkaistu: (2023-01-01)

Phase II study of a three-dose primary vaccination course of DTPa-IPV/Hib-MenC-TT followed by a 12-month Hib-MenC-TT booster in healthy infants.
Tekijä: Khatami, A, et al.
Julkaistu: (2013)

SAFETY AND IMMUNOGENICITY OF A NATIONAL COMBINED VACCINE AGAINST PERTUSSIS, DIPHTHERIA, TETANUS, HEPATITIS B AND Hib-INFECTION, CONTAINING ACELLULAR PERTUSSIS COMPONENT, DURING IMMUNIZATION OF ADULTS
Tekijä: I. V. Feldblyum, et al.
Julkaistu: (2016-02-01)

Phacomorphic glaucoma in Gambians
Tekijä: Chimdi M Chuka - Okosa
Julkaistu: (2003-01-01)

Immunogenicity and safety of a combined DTPa-IPV/Hib vaccine administered as a three-dose primary vaccination course in healthy Korean infants: phase III, randomized study
Tekijä: Ki Hwan Kim, et al.
Julkaistu: (2019-02-01)

Immunogenicity and safety of DTPW-HEPB-HIB (PRP-T) vaccine (Pentavac) in infants aged 2–7 months: a post marketing phase 4 clinical trial study
Tekijä: H. Masoumi-Asl, et al.
Julkaistu: (2024-10-01)

The Implementation of Pentavalent Vaccine DTaP/IPV/Hib within National Immunization Schedule
Tekijä: Irina V. Mikheeva, et al.
Julkaistu: (2019-09-01)

Impact of conjugate Haemophilus influenzae type b (Hib) vaccine introduction in South Africa
Tekijä: A von Gottberg, et al.
Julkaistu: (2006-10-01)